跳至主要内容
临床试验/NCT07841470
NCT07841470招募中2 期

Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia: Randomized Comparison of Pulsed vs. Non-pulsed Treatment

Price Vision Group1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
招募中
入组人数
500
试验地点
1
主要终点
Change in maximum keratometry

研究概览

简要总结

This randomized study compares 2 variations of corneal crosslinking for treatment of keratoconus or corneal ectasia.

详细描述

Subjects diagnosed with keratoconus or corneal ectasia are randomized to one of two corneal crosslinking light durations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
10 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of keratoconus or corneal ectasia
  • •Provision of written informed consent

排除标准

  • •Previous ocular condition in the study eye that may predispose for future complications including history of corneal disease (e.g., herpes simplex, herpes zoster keratitis, recurrent erosion syndrome, corneal melt, corneal dystrophy, etc.)
  • •Clinically significant corneal scarring in the proposed treatment zone
  • •History of chemical injury or delayed epithelial healing in the study eye
  • •Known sensitivity to study medication
  • •A current condition, including clinically significant dry eyes or use of medications know to induce dry eye symptoms, that, in the treating physician's opinion, would interfere with or prolong epithelial healing
  • •Pregnancy (including plan to become pregnant) or lactation during the course of the study

研究组 & 干预措施

Non-pulsed

Active Comparator

Treatment with 0.1% riboflavin eye drops non-pulsed 9 milliwatt/cm2 ultraviolet A light for 10 minutes

干预措施: Riboflavin 0.1% ophthalmic solution and non-pulsed light (Combination Product)

Pulsed

Active Comparator

Treatment with 0.1% riboflavin eye drops and pulsed 18 milliwatt/cm2 ultraviolet A light for 10 minutes

干预措施: Riboflavin 0.1% ophthalmic solution and pulsed light (Combination Product)

结局指标

主要结局

Change in maximum keratometry

时间窗: 6 months

assessed with corneal tomography

次要结局

  • change in corrected distance visual acuity(6 months)
  • change in uncorrected distance visual acuity(6 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Corneal Crosslinking for Treatment of Progressive... | 临床试验